Inflammatory breast cancer patients have increased chances of cancer spread to brain

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-10-11 03:30 GMT   |   Update On 2022-10-11 03:30 GMT
Advertisement
New research indicates that among individuals with breast cancer, those with a rare subtype called inflammatory breast cancer face a higher risk that their cancer will spread, or metastasize, to the brain.
To provide insights into the incidence and risk factors for brain metastases in this patient population, Laura E.G. Warren and her colleagues analyzed data on 372 patients with stage III inflammatory breast cancer and 159 with stage IV inflammatory breast cancer.
Advertisement
Over a median follow-up of 5 years, the incidence of brain metastases at 1, 2, and 5 years was 5%, 9%, and 18% among patients who presented with stage III disease, and 17%, 30%, and 42% among those with stage IV disease. Patients with triple-negative breast cancer faced a particularly high risk, and when they did experience brain metastases, their survival time was shorter than those with hormone receptor–positive or HER2-positive breast cancer who experienced brain metastases. Higher risks of brain metastases were also seen in patients whose cancer had metastasized to other parts of the body besides the brain, especially when this occurred at a young age.
Most patients in this study who were diagnosed with brain metastases had neurologic symptoms, but because some patients may have undetected, asymptomatic brain metastases, is likely even higher than what the researchers observed.
Reference:
"Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer." Laura E.G. Warren, Samuel M. Niman, Marie C. Remolano, Jean M. Landry, Faina Nakhlis, Jennifer R. Bellon, Ayal A. Aizer, Nancy U. Lin, Sara M. Tolaney, Meredith M. Regan, Beth A. Overmoyer, and Filipa Lynce. CANCER; Published Online: October 10, 2022 (DOI: 10.1002/cncr.34441).
Full View
Tags:    
Article Source : CANCER

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News